The effect of some urinary stone inhibitors on membrane interaction potentials of stone crystals.
The effect of stone growth inhibitors (citrate, pyrophosphate, ethane diphosphonate, methane diphosphonate, chondroitin sulfate A, chondroitin sulfate C, heparin and ribonucleic acid) on crystal-membrane interactions of whewellite, weddellite, apatite, brushite, struvite, uric acid, monosodium urate and quartz (control) stones was quantitated. As a model for the initial retention of microcrystals by kidney epithelial membranes, crystal-induced membranolysis of red blood cells served as a measure of crystal-membrane interactions. The inhibitors induced changes in hemolytic potential from approximately 320 per cent enhancement to 80 per cent inhibition. No inhibitor behaved the same way for all crystals studied. However, some crystals showed consistent trends in altered hemolytic potential in the presence of inhibitors. These crystals included weddellite and sodium urate, which were inhibited consistently, and apatite and quartz, which were enhanced consistently. Whewellite, uric acid, brushite and struvite exhibited mixed patterns in the altered hemolytic potentials owing to the inhibitors.
D002129:Calcium Oxalate / Q000037:antagonists & inhibitors*; D002809:Chondroitin Sulfates / Q000494:pharmacology; D002951:Citrates / Q000494:pharmacology; D019343:Citric Acid; D003460:Crystallization; D011756:Diphosphates / Q000494:pharmacology; D004164:Diphosphonates / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000187:drug effects*; D012968:Etidronic Acid / Q000494:pharmacology; D006461:Hemolysis; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D012313:RNA / Q000494:pharmacology; D014545:Urinary Calculi / Q000032:analysis*
D002951:Citrates; D011756:Diphosphates; D004164:Diphosphonates; D002129:Calcium Oxalate; D019343:Citric Acid; D012313:RNA; C027474:methylene diphosphonate; D006493:Heparin; D002809:Chondroitin Sulfates; D012968:Etidronic Acid